Maeda, Daichi
Dotare, Taishi
Matsue, Yuya
Teramoto, Kanako
Sunayama, Tsutomu
Tromp, Jasper
Minamino, Tohru
Article History
Received: 28 September 2022
Revised: 7 December 2022
Accepted: 12 December 2022
First Online: 5 January 2023
Compliance with ethical standards
:
: J.T. was supported by the National University of Singapore Start-up grant, the tier 1 grant from the Ministry of Education and the CS-IRG New Investigator Grant from the National Medical Research Council; received consulting or speaker fees from Daiichi-Sankyo, Boehringer Ingelheim, Roche Diagnostics and Us2.ai; and owns patent US-10702247-B2 unrelated to the present work. Y.M. received an honorarium from Otsuka Pharmaceutical Co, Novartis Pharma K.K., Bayer, Inc., and AstraZeneca and collaborative research grants from Pfizer Japan, Inc., Otsuka Pharmaceutical Co, EN Otsuka Pharmaceutical Co., Ltd., and Nippon Boehringer Ingelheim Co., Ltd. T.M. is an Associate Editor of Hypertension Research. The other authors have no other conflicts of interest to declare.